+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Omega-3 Fatty Acid Drugs Market - Global Forecast 2025-2030- Product Image
Omega-3 Fatty Acid Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Omega-3 Fatty Acid Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124284
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking actionable intelligence on the Omega-3 fatty acid therapeutics market will find this report delivers a strategic overview of clinical, regulatory, and supply chain dynamics shaping sector evolution. Competing stakeholders are actively redefining cardiovascular management as innovation and policy transformation advance across regions and product classes.

Market Snapshot: Omega-3 Fatty Acid Drug Landscape

The Omega-3 fatty acid drug market is experiencing significant transformation driven by advances in clinical research, evolving therapeutic guidelines, and increased demand for precision formulations. As key regulatory authorities adapt to new evidence, manufacturers, developers, and distributors are aligning their strategies to address shifting payer and patient expectations. Major players are investing in next-generation drug delivery technologies and patient-centric dosage forms, while broader industry trends emphasize supply chain resilience and competitive differentiation. A focus on high-purity eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulations, coupled with emerging digital health integrations, underpins growth and continuous innovation.

Scope & Segmentation

This Omega-3 fatty acid therapeutics report delivers a comprehensive analysis by indication, product type, dosage form, route of administration, distribution channel, manufacturer type, and therapeutic class. Regional perspectives cover the Americas, Europe, Middle East & Africa, and Asia-Pacific and include profiles of leading companies. Key segmentation includes:

  • Indication: Hypertriglyceridemia, Primary Prevention of Cardiovascular Disease, Secondary Prevention of Cardiovascular Disease (including post-myocardial infarction and stroke prevention)
  • Product Type: Ethyl Esters, Phospholipids, Triglycerides
  • Dosage Form: Capsules, Liquid, Soft Gels
  • Route of Administration: Oral, Parenteral
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Manufacturer Type: Branded, Generic
  • Therapeutic Class: Combination, Monotherapy
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key markets include United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Amarin Corporation plc, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Mylan N.V., Apotex Inc., Torrent Pharmaceuticals Ltd, Cipla Limited, Cadila Healthcare Limited, Sun Pharmaceutical Industries Limited

Key Takeaways

  • Omega-3 fatty acids have transitioned into cornerstone therapies in cardiovascular disease, with clinical evidence supporting their roles in lipid modulation, inflammation resolution, and endothelial function.
  • Drug developers are prioritizing high-purity EPA and DHA formulations with targeted dosages, alongside combination regimens leveraging established statins, enhancing risk reduction in diverse patient cohorts.
  • Pivotal clinical trials and evolving regulatory guidelines shape product positioning for hypertriglyceridemia, primary prevention, and secondary prevention post-cardiovascular events, fostering a nuanced approach to segment development.
  • Technological advancements, including microencapsulation, soft-gel innovation, and digital health monitoring, improve bioavailability, tolerability, and adherence for real-world patient outcomes.
  • Intensified competition results from patent expiration cycles, emerging generic entrants, and collaborative partnerships, compelling established players to develop distinct value propositions and supply chain resilience.
  • Global supply chain and tariff policies introduce complexity and margin pressures, driving realignment of procurement, sourcing strategies, and logistics across regions.

Tariff Impact: Strategic Implications

Recent United States tariffs have added challenges to Omega-3 fatty acid drug supply chains, affecting import costs for marine and algal raw materials. Industry response includes diversifying sourcing, forming joint ventures in tariff-exempt areas, and investing in backward integration to protect margins and maintain quality standards. As a result, competitive dynamics shift as companies recalibrate pricing, logistics, and distribution agreements.

Methodology & Data Sources

This analysis combines expert interviews, peer-reviewed literature, clinical trial registries, and policy reviews with quantitative methods. Economic modeling and statistical tools validate clinical and pricing trends, while strict data governance ensures reliability and actionable results.

Why This Report Matters

  • Enables evidence-based decisions by aligning regulatory developments, clinical advances, and market access challenges for Omega-3 fatty acid pharmaceuticals.
  • Provides a granular view of regional, segmental, and competitive landscapes, illuminating growth opportunities and white space innovation.
  • Furnishes practical recommendations on supply chain optimization, value-based pricing, and partnership strategies for sustainable growth.

Conclusion

This report delivers strategic foresight for navigating the evolving Omega-3 fatty acid drug market. Stakeholders can leverage these insights to drive innovation, expand access, and improve cardiovascular patient outcomes across global healthcare environments.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for high-purity EPA-only formulations in cardiovascular risk management
5.2. Advancements in nanoparticle delivery systems improving omega-3 fatty acid bioavailability
5.3. Impact of emerging generic competition on pricing dynamics for prescription omega-3 drugs
5.4. Expansion of combination therapies integrating omega-3 fatty acids for neurological disorders
5.5. Growing number of clinical trials testing omega-3 derivatives in psychiatric condition treatment
5.6. Regulatory shifts redefining EPA to DHA ratios in approved omega-3 lipid-lowering therapies
5.7. Market segmentation trends between over-the-counter supplements and prescription omega-3 drugs
5.8. Personalized medicine approaches leveraging genomic markers to optimize omega-3 drug response
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Omega-3 Fatty Acid Drugs Market, by Indication
8.1. Introduction
8.2. Hypertriglyceridemia
8.3. Primary Prevention of Cardiovascular Disease
8.4. Secondary Prevention of Cardiovascular Disease
8.4.1. Post Myocardial Infarction
8.4.2. Stroke Prevention
9. Omega-3 Fatty Acid Drugs Market, by Product Type
9.1. Introduction
9.2. Ethyl Esters
9.3. Phospholipids
9.4. Triglycerides
10. Omega-3 Fatty Acid Drugs Market, by Dosage Form
10.1. Introduction
10.2. Capsules
10.3. Liquid
10.4. Soft Gels
11. Omega-3 Fatty Acid Drugs Market, by Route of Administration
11.1. Introduction
11.2. Oral
11.3. Parenteral
12. Omega-3 Fatty Acid Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Omega-3 Fatty Acid Drugs Market, by Manufacturer Type
13.1. Introduction
13.2. Branded
13.3. Generic
14. Omega-3 Fatty Acid Drugs Market, by Therapeutic Class
14.1. Introduction
14.2. Combination
14.3. Monotherapy
15. Americas Omega-3 Fatty Acid Drugs Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Omega-3 Fatty Acid Drugs Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Omega-3 Fatty Acid Drugs Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Amarin Corporation plc
18.3.2. GlaxoSmithKline plc
18.3.3. Teva Pharmaceutical Industries Ltd
18.3.4. Dr. Reddy’s Laboratories Ltd
18.3.5. Mylan N.V.
18.3.6. Apotex Inc.
18.3.7. Torrent Pharmaceuticals Ltd
18.3.8. Cipla Limited
18.3.9. Cadila Healthcare Limited
18.3.10. Sun Pharmaceutical Industries Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. OMEGA-3 FATTY ACID DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. OMEGA-3 FATTY ACID DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. OMEGA-3 FATTY ACID DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. OMEGA-3 FATTY ACID DRUGS MARKET: RESEARCHAI
FIGURE 30. OMEGA-3 FATTY ACID DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 31. OMEGA-3 FATTY ACID DRUGS MARKET: RESEARCHCONTACTS
FIGURE 32. OMEGA-3 FATTY ACID DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OMEGA-3 FATTY ACID DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY HYPERTRIGLYCERIDEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY HYPERTRIGLYCERIDEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY POST MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY POST MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STROKE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STROKE PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ETHYL ESTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ETHYL ESTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PHOSPHOLIPIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PHOSPHOLIPIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SOFT GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SOFT GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 104. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 105. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 116. CANADA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 199. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 215. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 247. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 250. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 251. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 260. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 261. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 262. ITALY OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 263. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 276. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 277. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA OMEGA-3 FATTY ACID DRUGS MARKET SIZE, BY DISTRIBUTION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Omega-3 Fatty Acid Drugs market report include:
  • Amarin Corporation plc
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Mylan N.V.
  • Apotex Inc.
  • Torrent Pharmaceuticals Ltd
  • Cipla Limited
  • Cadila Healthcare Limited
  • Sun Pharmaceutical Industries Limited

Related Topics

Related Reports

Fatty Acid Supplements Market - Global Forecast 2025-2030 - Product Image

Fatty Acid Supplements Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Tallow Polyunsaturated Fatty Acid Market - Global Forecast 2025-2030 - Product Image

Tallow Polyunsaturated Fatty Acid Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview - Product Image

Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview

  • Report
  • 405 Pages
  • Global
From
2025 Omega-3 Fatty Acids Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Omega-3 Fatty Acids Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 155 Pages
  • Global
From
Fatty Acid Supplements - Global Strategic Business Report - Product Image

Fatty Acid Supplements - Global Strategic Business Report

  • Report
  • 311 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.